| November 25, 2011 |
REPLICor to disclose new
mechanism of action data and interim REP 9AC and REP 9AC’ clinical
efficacy data in patients with chronic hepatitis B at the 2011 HEPDART
meeting. |
| |
|
| October 27, 2011 |
REPLICor to disclose interim
REP 9AC clinical efficacy data in patients with chronic hepatitis B at
the 62nd annual meeting of the American Association for the Study of
Liver Diseases (AASLD 2011) |
| |
|
| March 30, 2011 |
REPLICor to disclose interim
REP 9AC clinical efficacy data in patients with chronic hepatitis B at
the 46th meeting of the European Association for the Study of the Liver
(EASL 2011) |
| |
|
| February 17, 2011 |
REPLICor to disclose interim
REP 9AC clinical efficacy data in patients with chronic hepatitis B at
the 21st Conference of the Asian Pacific
Association for the Study of
the Liver (APASL 2011) |
| |
|
| October 28, 2010 |
REPLICor to
disclose interim REP 9AC clinical efficacy data in patients with chronic
hepatitis B at the 61st annual meeting of the AASLD in Boston, U.S.A. |
| |
|
| March 18, 2010 |
REPLICor to present interim
REP 9AC clinical efficacy data at the 20th annual meeting of the APASL in
Beijing, China |
| |
|
| December 8, 2009 |
Dr. Allison Jilbert presents
preclinical efficacy data for REP 9AC in DHBV infected Pekin ducks |
| |
|
| December 2, 2009 |
REPLICor publishes data on
the activity and safety of amphipathic DNA polymers (APs) in cytomegalovirus
infection |
| |
|
| April 23, 2009 |
Publication of REPLICor’s first in class HCV entry
inhibitor based on its amphipathic DNA polymer technology |
| |
|
| April 16, 2009 |
REPLICor publishes data on
mechanism of action and pre-clinical efficacy of amphipathic DNA polymers (APs)
in HCV infection |
| |
|
| March 31, 2009 |
REPLICor to present preclinical data showing a curative response to
hepatitis B infection with its drug at the 1st Annual
Girindus Leaders in Oligonucletides Meeting |
| |
|
| March, 2009 |
REPLICor initiates dosing of human patients with
its drug |
| |
|
| February, 2009 |
REPLICor receives IRB approval to conduct
a phase I / II trial to test the safety and efficacy of its drug in
patients with chronic hepatitis B and hepatitis C |
| |
|
|
April 13, 2008 |
REPLICor to Present
at the 21st International Conference on Antiviral Research |
| |
|
|
January 10, 2008
|
REPLICor : Une
Entreprise Audacieuse (French only) |
| |
|
| December 06, 2007 |
REPLICor’s Data on REP 9C / REP 9AC Presented
at the HEPDART Meeting |
| |
|
|
December 04, 2007 |
REPLICor Recognized as a Top 10 Life Sciences
Companies in Canada |
| |
|
|
November 30, 2007 |
REPLICor Receives Notice of Allowance for Key
Patent Application |
| |
|
|
September 16, 2007 |
REPLICor to Present at the RSC Virus Molecular
Interactions Conference |
| |
|
|
September 10, 2007 |
REPLICor Collaborators to Present at the HBV
Meeting |
| |
|
|
September 08, 2007 |
REPLICor
to Present at the 14th Symposium of Hepatitis C and Related
Viruses |
| |
|
|
April 23, 2007 |
REPLICor to Present at 20th International
Conference on Antiviral Research |
| |
|
|
February 28, 2007 |
REPLICor to Present at the 3rd Annual Viral Hepatitis in Drug Discovery &
Development World Summit |
| |
|
|
October 24, 2006 |
REPLICor to disclose results of its first-in-class drugs against
hepatitis C |
| |
|
|
September 19, 2006 |
REPLICor's Drug Activity in the Metabolic Syndrome |
| |
|
|
June 21, 2006 |
REPLICor
Presenting at Metabolic Diseases Summit |
| |
|
|
May 05, 2006 |
REPLICor to present at the American Society for
Microbiology General Meeting 2006 |
| |
|
|
May 05, 2006 |
REPLICor to present at the 19th International
Conference on Antiviral Research |
| |
|
|
May 05, 2006 |
Oligos Enable New Classes of Therapeutics |
| |
|
|
April 28, 2006 |
REPLICor to
present at TIDES 2006 |
| |
|
|
April 22, 2006 |
REPLICor, NIAID identify potential anti-prion therapeutic |
| |
|
|
April 5, 2006 |
REPLICor’s Antiviral Drug Is Active
against H5N1 Avian Flu |
| |
|
| November 1st, 2005 |
REPLICor’s Antiviral Drug Promises Potent Activity
against H5N1 Avian Flu |
| |
|
| April 11, 2005 |
REPLICor Describes its Corporate Strategies in the
Biomed Business Journal |
| |
|
| March 30, 2005 |
REPLICor
to Disclose Unique Broad Spectrum Antiviral Drug |
| |
|
|
November 10, 2004 |
Girindus to Produce
Antiviral Treatment for Canada's Replicor |
| |
|
|
November 8, 2004 |
REPLICor Named One of Canada’s Top Ten Life Science
Companies |